A redox/methylation hypothesis of drug addiction

Frontiers in Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Trivedi, Malav ^a   Deth, Richard ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CPG OLIGODEOXYNUCLEOTIDE; GLUTATHIONE; OPIATE; PSYCHOSTIMULANT AGENT;

ALCOHOLISM; BRAIN METABOLISM; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DRUG DEPENDENCE; EPIGENETICS; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROCHROMATIN; OXIDATIVE STRESS; PALLIATIVE THERAPY; REVIEW; WITHDRAWAL SYNDROME;

EID: 84920661451     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00444     Document Type: Review

References (118)

1. Adibhatla, R. M., and Hatcher, J. F. (2010). Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 12, 125-169.
2. Alhaddad, H., Das, S. C., and Sari, Y. (2014a). Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats. Psychopharmacology (Berl.) 231, 4049-4057.
3. Alhaddad, H., Kim, N. T., Aal-Aaboda, M., Althobaiti, Y. S., Leighton, J., Boddu, S. H. S., Wei, Y., and Sari, Y. (2014b). Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. Front. Behav. Neurosci. 8, 366.
4. Augustyniak, A., Michalak, K., and Skrzydlewska, E. (2005). [The action of oxidative stress induced by ethanol on the central nervous system (CNS)]. Post?py Hig. Med. Dosw. Online 59, 464-471.
5. Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Toda, S., and Kalivas, P. W. (2003). N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann. N. Y. Acad. Sci. 1003, 349-351.
6. Bao, X., Hui, D., Näassila, M., and Michaelis, E. K. (2001). Chronic ethanol exposure increases gene transcription of subunits of an N-methyl-D-aspartate receptor-like complex in cortical neurons in culture. Neurosci. Lett. 315, 5-8.
7. Barak, A. J., Beckenhauer, H. C., Tuma, D. J., and Badakhsh, S. (1987). Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem. Cell Biol. Biochim. Biol. Cell. 65, 230-233.
8. Bardag-Gorce, F., French, B. A., Joyce, M., Baires, M., Montgomery, R. O., Li, J., and French, S. (2007). Histone acetyltransferase p300 modulates gene expression in an epigenetic manner at high blood alcohol levels. Exp. Mol. Pathol. 82, 197-202.
9. Bellizzi, D., D'Aquila, P., Scafone, T., Giordano, M., Riso, V., Riccio, A., and Passarino, G. (2013). The Control Region of Mitochondrial DNA Shows an Unusual CpG and Non-CpG Methylation Pattern. DNA Res. Int. J. Rapid Publ. Rep. Genes Genomes 20, 537-547.
10. Benzecry, J. M., Power-Charnitsky, V.-A., Deth, R. C., Waly, M., Olteanu, H., Banerjee, R., Choi, S.-W., Mason, J. B., Parker, B. S., Sukumar, S., et al. (2004). Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol. Psych. 9, 358-370.
11. Bhat, R. S., Bhaskaran, M., Mongia, A., Hitosugi, N., and Singhal, P. C. (2004). Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol.75(6):1131-8.
12. Carvalho, F., Fernandes, E., Remião, F., Gomes-Da-Silva, J., Tavares, M. A., and Bastos, M. D. L. (2001). Adaptative response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration. Addict. Biol. 6, 213-221.
13. Carvalho, F., Fernandes, E., Remião, F., and de Lourdes Bastos, M. (1999). Effect of damphetamine repeated administration on rat antioxidant defences. Arch. Toxicol. 73, 83-89.
14. Chandler, L. J., Norwood, D., and Sutton, G. (1999). Chronic ethanol upregulates NMDA and AMPA, but not kainate receptor subunit proteins in rat primary cortical cultures. Alcohol. Clin. Exp. Res. 23, 363-370.
15. Chandramani Shivalingappa, P., Jin, H., Anantharam, V., Kanthasamy, A., and Kanthasamy, A. (2012). N-Acetyl Cysteine Protects against Methamphetamine-Induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic Cells. Park. Dis. 2012, e424285.
16. Chao, J., and Nestler, E. J. (2004). Molecular neurobiology of drug addiction. Annu. Rev. Med. 55, 113-132.
17. Christie, M. J. (2008). Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br. J. Pharmacol. 154, 384-396.
18. Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261.
19. Dean, O., Giorlando, F., and Berk, M. (2011). N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J. Psych. Neurosci. 36, 78-86.
20. Deavall, D. G., Martin, E. A., Horner, J. M., and Roberts, R. (2012). Drug-Induced Oxidative Stress and Toxicity. J. Toxicol. 2012, e645460.
21. Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., and Waly, M. (2008). How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicol. 29, 190-201.
22. Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., and Berk, M. (2008). N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin. Biol. Ther. 8, 1955-1962.
23. Dolzhanskaya, N., Merz, G., Aletta, J. M., and Denman, R. B. (2006). Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP. J. Cell Sci. 119, 1933-1946.
24. Dong, J., Sulik, K. K., and Chen, S.-Y. (2008). Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox Signal. 10, 2023-2033.
25. Ernst, T., Chang, L., Leonido-Yee, M., and Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 54, 1344-1349.
26. Escartin, C., Won, S. J., Malgorn, C., Auregan, G., Berman, A. E., Chen, P.-C., Déglon, N., Johnson, J. A., Suh, S. W., and Swanson, R. A. (2011). Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression. J. Neurosci. 31, 7392-7401.
27. Finkelstein, J. D., Kyle, W. E., Martin, J. L., and Pick, A. M. (1975). Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem. Biophys. Res. Commun. 66, 81-87.
28. Flores, K. G., Stidley, C. A., Mackey, A. J., Picchi, M. A., Stabler, S. P., Siegfried, J. M., Byers, T., Berwick, M., Belinsky, S. A., and Leng, S. (2012). Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers. Carcinogenesis. 33(8):1542-7.
29. Follesa, P., and Ticku, M. K. (1995). Chronic ethanol treatment differentially regulates NMDA receptor subunit mRNA expression in rat brain. Brain Res. Mol. Brain Res. 29, 99-106.
30. Fritsch, L., Robin, P., Mathieu, J. R. R., Souidi, M., Hinaux, H., Rougeulle, C., Harel-Bellan, A., Ameyar-Zazoua, M., and Ait-Si-Ali, S. (2010). A Subset of the Histone H3 Lysine 9 Methyltransferases Suv39h1, G9a, GLP, and SETDB1 Participate in a Multimeric Complex. Mol. Cell 37, 46-56.
31. Gardiner-Garden, M., and Frommer, M. (1994). Transcripts and CpG islands associated with the pro-opiomelanocortin gene and other neurally expressed genes. J. Mol. Endocrinol. 12, 365-382.
32. Gipson, C. D., Reissner, K. J., Kupchik, Y. M., Smith, A. C. W., Stankeviciute, N., Hensley-Simon, M. E., and Kalivas, P. W. (2013). Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc. Natl. Acad. Sci. U. S. A. 110, 9124-9129.
33. Goudas, L. C., Langlade, A., Serrie, A., Matson, W., Milbury, P., Thurel, C., Sandouk, P., and Carr, D. B. (1999). Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain. Anesth. Analg. 89, 1209-1215.
34. Grant, K. A., Valverius, P., Hudspith, M., and Tabakoff, B. (1990). Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmacol. 176, 289-296.
35. Guidotti, A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., Grayson, D. R., Matrisciano, F., Pinna, G., Satta, R., et al. (2011). Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacol. 60, 1007-1016.
36. Gulya, K., Grant, K. A., Valverius, P., Hoffman, P. L., and Tabakoff, B. (1991). Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 547, 129-134.
37. Gutowicz, M., Kazmierczak, B., and Baranczyk-Kuzma, A. (2011). The influence of heroin abuse on glutathione-dependent enzymes in human brain. Drug Alcohol Depend. 113, 8-12.
38. Guzmán, D. C., Vázquez, I. E., Brizuela, N. O., Alvarez, R. G., Mejía, G. B., García, E. H., Santamaría, D., de Apreza, M. la R., and Olguín, H. J. (2006). Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brain. Neurochem. Res. 31, 549-554.
39. Homer, B. D., Solomon, T. M., Moeller, R. W., Mascia, A., DeRaleau, L., and Halkitis, P. N. (2008). Methamphetamine abuse and impairment of social functioning: A review of the underlying neurophysiological causes and behavioral implications. Psychol. Bull. 134, 301-310.
40. Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006). Neural Mechanisms of Addiction: The Role of Reward-Related Learning and Memory. Annu. Rev. Neurosci. 29, 565-598.
41. Illingworth, R. S., Gruenewald-Schneider, U., Webb, S., Kerr, A. R. W., James, K. D., Turner, D. J., Smith, C., Harrison, D. J., Andrews, R., and Bird, A. P. (2010). Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome. PLoS Genet 6, e1001134.
42. Jing, L., Luo, J., Zhang, M., Qin, W.-J., Li, Y.-L., Liu, Q., Wang, Y.-T., Lawrence, A. J., and Liang, J.-H. (2011). Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. Neurosci. Lett. 494, 169-173.
43. Kalluri, H. S., Mehta, A. K., and Ticku, M. K. (1998). Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Brain Res. Mol. Brain Res. 58, 221-224.
44. Kim, J.-H., Lim, Y.-J., Ro, Y.-J., Min, S.-W., Kim, C.-S., Do, S.-H., Kim, Y.-L., and Zuo, Z. (2003). Effects of ethanol on the rat glutamate excitatory amino acid transporter type 3 expressed in Xenopus oocytes: role of protein kinase C and phosphatidylinositol 3-kinase. Alcohol. Clin. Exp. Res. 27, 1548-1553.
45. Knackstedt, L. A., and Kalivas, P. W. (2009). Glutamate and reinstatement. Curr. Opin. Pharmacol. 9, 59-64.
46. Knackstedt, L. A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Markou, A., and Kalivas, P. W. (2009). The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol. Psych. 65, 841-845.
47. Knackstedt, L. A., Melendez, R. I., and Kalivas, P. W. (2010). Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine-seeking. Biol. Psych. 67, 81-84.
48. Kobayashi, L. C., Limburg, H., Miao, Q., Woolcott, C., Bedard, L. L., Massey, T. E., and Aronson, K. J. (2012). Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions. Front. Oncol. eCollection; 2, 100-105.
49. Krasnova, I. N., and Cadet, J. L. (2009). Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379-407.
50. Kumari, M., and Ticku, M. K. (2000). Regulation of NMDA receptors by ethanol. Prog. Drug Res. Fortschritte Arzneimittelforschung Prog. Rech. Pharm. 54, 152-189.
51. LaRowe, S. D., Mardikian, P., Malcolm, R., Myrick, H., Kalivas, P., McFarland, K., Saladin, M., McRae, A., and Brady, K. (2006). Safety and Tolerability of NAcetylcysteine in Cocaine-Dependent Individuals. Am. J. Addict. Am. Acad. Psychiatr. Alcohol. Addict. 15, 105-110.
52. Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008). Glutathione precursor, Nacetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33, 2187-2199.
53. Lee, K. K., and Workman, J. L. (2007). Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 284-295.
54. Levine, A., Huang, Y., Drisaldi, B., Griffin, E. A., Pollak, D. D., Xu, S., Yin, D., Schaffran, C., Kandel, D. B., and Kandel, E. R. (2011). Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine. Sci. Transl. Med. 3, 107-109.
55. Li, H., Bu, Q., Chen, B., Shao, X., Hu, Z., Deng, P., Lv, L., Deng, Y., Zhu, R., Li, Y., et al. (2014). Mechanisms of metabonomic for a gateway drug: nicotine priming enhances behavioral response to cocaine with modification in energy metabolism and neurotransmitter level. PloS One 9, e87040.
56. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322.
57. Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., and Misteli, T. (2011). Epigenetics in alternative pre-mRNA splicing. Cell 144, 16-26.
58. Lu, S. C., Huang, Z.-Z., Yang, H., Mato, J. M., Avila, M. A., and Tsukamoto, H. (2000). Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am. J. Physiol. -Gastrointest. Liver Physiol. 279, G178-G185.
59. Lu, S. C., Tsukamoto, H., and Mato, J. M. (2002). Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 27, 155-162.
60. Macleod, D., Ali, R. R., and Bird, A. (1998). An Alternative Promoter in the Mouse Major Histocompatibility Complex Class II I-A? Gene: Implications for the Origin of CpG Islands. Mol. Cell. Biol. 18, 4433-4443.
61. Mannelli, P., Patkar, A., Rozen, S., Matson, W., Krishnan, R., and Kaddurah-Daouk, R. (2009). Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum. Psychopharmacology 24, 666-675.
62. Manzanedo, C., García-Pardo, M. P., Rodríguez-Arias, M., Miñarro, J., and Aguilar, M. A. (2012). Pre-treatment with high doses of cocaine decreases the reinforcing effects of cocaine in the conditioned place preference paradigm. Neurosci. Lett. 516, 29-33.
63. Mao, J., Sung, B., Ji, R.-R., and Lim, G. (2002). Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22, 8312-8323.
64. Martin, W. R., and Fraser, H. F. (1961). A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J. Pharmacol. Exp. Ther. 133, 388-399.
65. Marutha Ravindran, C. R., and Ticku, M. K. (2004). Changes in methylation pattern of NMDA receptor NR2B gene in cortical neurons after chronic ethanol treatment in mice. Brain Res. Mol. Brain Res. 121, 19-27.
66. Marutha Ravindran, C. R., and Ticku, M. K. (2005). Role of CpG islands in the upregulation of NMDA receptor NR2B gene expression following chronic ethanol treatment of cultured cortical neurons of mice. Neurochem. Int. 46, 313-327.
67. Maze, I., Covington, H. E., 3rd, Dietz, D. M., LaPlant, Q., Renthal, W., Russo, S. J., Mechanic, M., Mouzon, E., Neve, R. L., Haggarty, S. J., et al. (2010). Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327, 213-216.
68. Maze, I., Feng, J., Wilkinson, M. B., Sun, H., Shen, L., and Nestler, E. J. (2011). Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 108, 3035-3040.
69. Maze, I., and Nestler, E. J. (2011). The epigenetic landscape of addiction. Ann N Y Acad Sci 1216, 99-113.
70. Mazei-Robison, M. S., and Nestler, E. J. (2012). Opiate-Induced Molecular and Cellular Plasticity of Ventral Tegmental Area and Locus Coeruleus Catecholamine Neurons. Cold Spring Harb. Perspect. Med. 2 (7):a012070.
71. McClung, C. A., Nestler, E. J., and Zachariou, V. (2005). Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 25, 6005-6015.
72. Mudd, S. H., Ebert, M. H., and Scriver, C. R. (1980). Labile methyl group balances in the human: the role of sarcosine. Metabolism. 29, 707-720.
73. Muratore, C. R., Hodgson, N. W., Trivedi, M. S., Abdolmaleky, H. M., Persico, A. M., Lintas, C., De La Monte, S., and Deth, R. C. (2013). Age-Dependent Decrease and Alternative Splicing of Methionine Synthase mRNA in Human Cerebral Cortex and an Accelerated Decrease in Autism. PLoS ONE 8, e56927.
74. Nakagawa, T., Fujio, M., Ozawa, T., Minami, M., and Satoh, M. (2005). Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav. Brain Res. 156, 233-239.
75. Nakagawa, T., Ozawa, T., Shige, K., Yamamoto, R., Minami, M., and Satoh, M. (2001). Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur. J. Pharmacol. 419, 39-45.
76. Nestler, E. J. (2002). Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 78, 637-647.
77. Pan, T. (2013). N6-methyl-adenosine modification in messenger and long non-coding RNA. Trends Biochem. Sci. 38, 204-209.
78. Peter, C. J., and Akbarian, S. (2011). Balancing histone methylation activities in psychiatric disorders. Trends Mol. Med. 17, 372-379.
79. Pogribny, I. P., Basnakian, A. G., Miller, B. J., Lopatina, N. G., Poirier, L. A., and James, S. J. (1995). Breaks in Genomic DNA and within the p53 Gene Are Associated with Hypomethylation in Livers of Folate/methyl-deficient Rats. Cancer Res. 55, 1894-1901.
80. Potter, C., McKay, J., Groom, A., Ford, D., Coneyworth, L., Mathers, J. C., and Relton, C. L. (2013). Influence of DNMT Genotype on Global and Site Specific DNA Methylation Patterns in Neonates and Pregnant Women. PLoS ONE 8, e76506.
81. Prudova, A., Bauman, Z., Braun, A., Vitvitsky, V., Lu, S. C., and Banerjee, R. (2006). Sadenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc. Natl. Acad. Sci. U. S. A. 103, 6489-6494.
82. Rao, P. S. S., and Sari, Y. (2014). Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats. J. Mol. Neurosci. 54, 71-77.
83. Rehni, A. K., Singh, N., Rachamalla, M., and Tikoo, K. (2012). Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. Naunyn. Schmiedebergs Arch. Pharmacol. 385, 605-619.
84. Reichel, C. M., Moussawi, K., Do, P. H., Kalivas, P. W., and See, R. E. (2011). Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J. Pharmacol. Exp. Ther. 337, 487-493.
85. Reissner, K. J., Gipson, C. D., Tran, P. K., Knackstedt, L. A., Scofield, M. D., and Kalivas, P. W. (2014). Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement. Addict. Biol. 10,12127.
86. Renthal, W., and Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends Mol. Med. 14, 341-350.
87. Robison, A. J., and Nestler, E. J. (2011a). Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 12, 623-637.
88. Ronis, M. J. J., Butura, A., Sampey, B. P., Shankar, K., Prior, R. L., Korourian, S., Albano, E., Ingelman-Sundberg, M., Petersen, D. R., and Badger, T. M. (2005). Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic. Biol. Med. 39, 619-630.
89. Ruiz, F., Corrales, F. J., Miqueo, C., and Mato, J. M. (1998). Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation. Hepatol. 28, 1051-1057.
90. Saffroy, R., Benyamina, A., Pham, P., Marill, C., Karila, L., Reffas, M., Debuire, B., Reynaud, M., and Lemoine, A. (2008). Protective effect against alcohol dependence of the thermolabile variant of MTHFR. Drug Alcohol Depend. 96, 30-36.
91. Sánchez-Góngora, E., Ruiz, F., Mingorance, J., An, W., Corrales, F. J., and Mato, J. M. (1997). Interaction of liver methionine adenosyltransferase with hydroxyl radical. FASEB 11, 1013-1019.
92. Sanchis-Segura, C., Lopez-Atalaya, J. P., and Barco, A. (2009). Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition. Neuropsychopharmacology 34, 2642-2654.
93. Sari, Y., and Sreemantula, S. N. (2012). Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neurosci. 227, 327-335.
94. Sari, Y., Sreemantula, S. N., Lee, M. R., and Choi, D.-S. (2013). Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcoholpreferring rats. J. Mol. Neurosci. 51, 779-787.
95. Schwarz, J. M., Hutchinson, M. R., and Bilbo, S. D. (2011). Early-Life Experience Decreases Drug-Induced Reinstatement of Morphine CPP in Adulthood via Microglial-Specific Epigenetic Programming of Anti-Inflammatory IL-10 Expression. J. Neurosci. 31, 17835-17847.
96. Scofield, M. D., and Kalivas, P. W. (2014). Astrocytic Dysfunction and Addiction: Consequences of Impaired Glutamate Homeostasis. Neurosci. Rev. J. Neurobiol. Neurol. Psych. 20, 610-622.
97. Sheng, J., Lv, Z. gang, Wang, L., Zhou, Y., and Hui, B. (2011). Histone H3 phosphoacetylation is critical for heroin-induced place preference. Neuroreport 22, 575-580.
98. Shimada, F., Shiga, Y., Morikawa, M., Kawazura, H., Morikawa, O., Matsuoka, T., Nishizaki, T., and Saito, N. (1999). The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386, 263-270.
99. Shinkai, Y., and Tachibana, M. (2011). H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 25, 781-788.
100. Shin, S., Stewart, R., Ferri, C. P., Kim, J.-M., Shin, I.-S., Kim, S.-W., Yang, S.-J., and Yoon, J.-S. (2010). An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. Int. J. Geriatr. Psych. 25, 441-448.
101. Spijker, S., Houtzager, S. W. J., De Gunst, M. C. M., De Boer, W. P. H., Schoffelmeer, A. N. M., and Smit, A. B. (2004). Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens. FASEB 18, 848-850.
102. Stephans, S. E., and Yamamoto, B. K. (1994). Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17, 203-209.
103. Sun, H., Maze, I., Dietz, D. M., Scobie, K. N., Kennedy, P. J., Damez-Werno, D., Neve, R. L., Zachariou, V., Shen, L., and Nestler, E. J. (2012). Morphine Epigenomically Regulates Behavior through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens. J. Neurosci. 32, 17454-17464.
104. Tegeder, I., and Geisslinger, G. (2004). Opioids As Modulators of Cell Death and Survival-Unraveling Mechanisms and Revealing New Indications. Pharmacol. Rev. 56, 351-369.
105. Thomas, M. P., and Morrisett, R. A. (2000). Dynamics of NMDAR-mediated neurotoxicity during chronic ethanol exposure and withdrawal. Neuropharmacol. 39, 218-226.
106. Trivedi, M. S., and Deth, R. C. (2012). Role of a Redox-Based Methylation Switch in mRNA Life Cycle (Pre-and Post-Transcriptional Maturation) and Protein Turnover: Implications in Neurological Disorders. Front. Neurosci. eCollection;6:92
107. Trivedi, M., Shah, J., Hodgson, N., Byun, H.-M., and Deth, R. (2014a). Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino Acid transporter type 3-mediated cysteine uptake. Mol. Pharmacol. 85, 747-757.
108. Trivedi, M. S., Shah, J. S., Al-Mughairy, S., Hodgson, N. W., Simms, B., Trooskens, G. A., Van Criekinge, W., and Deth, R. C. (2014b). Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences. J. Nutr. Biochem. 10,1011-8.
109. Tsankova, N., Renthal, W., Kumar, A., and Nestler, E. J. (2007). Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355-367.
110. Villanueva, J. A., and Halsted, C. H. (2004). Hepatic transmethylation reactions in micropigs with alcoholic liver disease. Hepatol. 39, 1303-1310.
111. Waly, M. I., Kharbanda, K. K., and Deth, R. C. (2011). Ethanol Lowers Glutathione in Rat Liver and Brain and Inhibits Methionine Synthase in a Cobalamin-dependent Manner. Alcohol. Clin. Exp. Res. 35, 277-283.
112. Wellen, K. E., and Thompson, C. B. (2012). A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270-276.
113. Wolf, A., Agnihotri, S., Munoz, D., and Guha, A. (2011). Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme. Neurobiol. Dis. 44, 84-91.
114. Xu, B., Wang, Z., Li, G., Li, B., Lin, H., Zheng, R., and Zheng, Q. (2006). Heroinadministered mice involved in oxidative stress and exogenous antioxidantalleviated withdrawal syndrome. Basic Clin. Pharmacol. Toxicol. 99, 153-161.
115. Xu, N.-J., Bao, L., Fan, H.-P., Bao, G.-B., Pu, L., Lu, Y.-J., Wu, C.-F., Zhang, X., and Pei, G. (2003). Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J. Neurosci. 23, 4775-4784.
116. Yang, L., Wang, S., Lim, G., Sung, B., Zeng, Q., and Mao, J. (2008a). Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance. Pain 140, 472-478.
117. Yang, L., Wang, S., Sung, B., Lim, G., and Mao, J. (2008b). Morphine induces ubiquitinproteasome activity and glutamate transporter degradation. J. Biol. Chem. 283, 21703-21713.
118. Zhou, W., and Kalivas, P. W. (2008). N-acetylcysteine reduces extinction responding and induces enduring reductions in cue-and heroin-induced drug-seeking. Biol. Psych. 63, 338-340.